Robust sars?cov?2 antibody responses in asian covid?naïve subjects 180 days after two doses of bnt162b2 mrna covid?19 vaccine
10.3390/vaccines9111241
Saved in:
Main Authors: | Lau, Chin-Shern, Phua, Soon Kieng, Liang, Ya-Li, Oh, Helen May-Lin, Aw, Tar-Choon |
---|---|
Other Authors: | PATHOLOGY |
Format: | Article |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/232376 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
by: Lau, C. S., et al.
Published: (2022) -
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine
by: Low, Jenny G., et al.
Published: (2023) -
Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV
by: Manopo, I., et al.
Published: (2012) -
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB
by: Chang, Zi Wei, et al.
Published: (2023) -
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)